TSX:CURAPharmaceuticals
Curaleaf Holdings Q1 Profit Challenges Long Running Loss Narrative For TSX Cura
Curaleaf Holdings (TSX:CURA) opened Q1 2026 with revenue of US$324.2 million and basic EPS of US$0.09, while the trailing twelve months showed revenue of about US$1.29 billion and a basic EPS loss of US$0.15. Over recent quarters the company has seen revenue move from US$306.6 million in Q1 2025 to US$324.2 million in Q1 2026, as quarterly EPS shifted from a US$0.09 loss to US$0.09. This has put the spotlight firmly on how sustainable these margins are and the path to consistent...